Quinapril Tablets
» Quinapril Tablets contain an amount of Quinapril Hydrochloride equivalent to not less than 90.0 percent and not more than 110.0 percent of the labeled amount of quinapril (C25H30N2O5).
Packaging and storage— Preserve in well-closed containers. Store at controlled room temperature.
USP Reference standards 11
USP Quinapril Hydrochloride RS Click to View Structure
USP Quinapril Related Compound A RS
Ethyl [3S-[(2R*), 3a, 11ab]]-1,3,4,6,11,11a-hexahydro-3-methyl-1,4-dioxo-a-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetate.
    C25H27N2O4    419.49
USP Quinapril Related Compound B RS
3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]-1,2,3,4-tetrahydro-, [3S-[2[R*(R*)],3R*]].
    C23H26N2O5    410.47
Identification—
A: Thin-Layer Chromatographic Identification Test 201
Test solution— Transfer a quantity of finely powdered Tablets, equivalent to about 10.0 mg of quinapril, to a 15-mL centrifuge tube; add 5 mL of methanol; mix; and centrifuge for 10 minutes.
Standard solution— Transfer about 10.8 mg of USP Quinapril Hydrochloride RS to a 15-mL centrifuge tube, add 5 mL of methanol, mix, and centrifuge for 10 minutes.
Application volume: 25 µL.
Developing solvent system: a mixture of methanol and ethyl acetate (1:1).
Procedure— Proceed as directed in the chapter, except to wash the plate in methanol and air-dry it prior to use.
B: The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
Dissolution 711
Medium: water; 900 mL.
Apparatus 1: 100 rpm.
Time: 30 minutes.
Procedure— Determine the amount of C25H30N2O5 dissolved by employing the procedure set forth in the Assay, using a filtered portion of the solution under test as the Assay preparation, using methanol to prepare the Standard preparation, and making any necessary volumetric adjustments with water.
Tolerances— Not less than 80% (Q) of the labeled amount of C25H30N2O5 is dissolved in 30 minutes.
Uniformity of dosage units 905: meet the requirements.
procedure for content uniformity—
Solvent, Buffered solvent, Mobile phase, and Chromatographic system— Prepare as directed in the Assay.
Standard solution— Prepare as directed for Standard preparation in the Assay.
Test solution— Transfer 1 Tablet to a volumetric flask. Add a volume of Solvent, equivalent to about one-half the flask volume; sonicate for 5 minutes; and shake by mechanical means for about 15 minutes. Dilute with Solvent to volume, mix, and pass through a suitable filter, discarding the first portion of the filtrate. Dilute a portion of the filtrate quantitatively, and stepwise if necessary, with Solvent to obtain a solution containing about 0.108 mg of quinapril hydrochloride per mL.
Procedure— Separately inject equal volumes (about 20 µL) of the Standard solution and the Test solution into the chromatograph, record the chromatograms, and measure the areas of the major peaks. Calculate the quantity, in mg, of quinapril (C25H30N2O5) in each Tablet taken by the formula:
(438.52/474.98)C(L/D)(rU / rS)
in which 438.52 and 474.98 are the molecular weights of quinapril and quinapril hydrochloride, respectively; C is the concentration, in mg per mL, of USP Quinapril Hydrochloride RS in the Standard solution; L is the labeled quantity, in mg, of quinapril in each Tablet; D is the concentration, in mg per mL, of quinapril hydrochloride in the Test solution; and rU and rS are the quinapril peak areas obtained from the Test solution and the Standard solution, respectively.
Related compounds—
Solvent, Buffered solvent, and Mobile phase— Prepare as directed in the Assay.
Resolution solution— Dissolve accurately weighed quantities of USP Quinapril Hydrochloride RS, USP Quinapril Related Compound A RS, and USP Quinapril Related Compound B RS in Solvent to obtain a solution having known concentrations of about 0.1 mg of USP Quinapril Hydrochloride RS and 0.005 mg each of USP Quinapril Related Compound A RS and USP Quinapril Related Compound B RS per mL.
Standard solution— Dissolve accurately weighed quantities of USP Quinapril Hydrochloride RS, USP Quinapril Related Compound A RS, and USP Quinapril Related Compound B RS in Solvent, and dilute quantitatively, and stepwise if necessary, to obtain a solution having known concentrations of about 0.5 µg each of USP Quinapril Hydrochloride RS, USP Quinapril Related Compound A RS, and USP Quinapril Related Compound B RS per mL.
Test solution— Use the Assay preparation.
Chromatographic system— Prepare as directed in the Assay. Chromatograph the Resolution solution, and record the peak areas as directed for Procedure: the relative retention times are about 0.6 for quinapril related compound B, 1.0 for quinapril, and 2.0 for quinapril related compound A; and the resolution, R, between quinapril and quinapril related compound A and between quinapril and quinapril related compound B is not less than 2.0. Chromatograph the Standard solution, and record the peak areas as directed for Procedure: the column efficiency is not less than 600 theoretical plates; the tailing factor for the quinapril and quinapril related compound A peaks is less than 1.5 and that for the quinapril related compound B peak is less than 2.0; and the relative standard deviation for replicate injections is not more than 2.0% for quinapril and not more than 3.0% for each quinapril related compound.
Procedure— Separately inject equal volumes (about 20 µL) of the Standard solution and the Test solution into the chromatograph, record the chromatograms, and measure the areas of the major peaks. Calculate the quantity, in mg, of each quinapril related compound in the portion of Tablets taken by the formula:
500CD(rU / rS)
in which C is the concentration, in mg per mL, of the appropriate USP Reference Standard in the Standard solution; D is the dilution factor used to prepare the Test solution; and rU and rS are the peak areas of the corresponding quinapril related compound obtained from the Test solution and the Standard solution, respectively: not more than 1.0% of quinapril related compound A is found; not more than 3.0% of quinapril related compound B is found; and not more than 3.6% of total impurities is found.
Assay—
Solvent— Prepare a mixture of water and acetonitrile (65:35).
Buffered solvent— Prepare a mixture of pH 6.5, 0.05 M dibasic potassium phosphate and acetonitrile (65:35).
Mobile phase— Prepare a filtered and degassed mixture of water, acetonitrile, and methanesulfonic acid (65:35:0.2). Make adjustments if necessary (see System Suitability under Chromatography 621).
Standard preparation— Dissolve an accurately weighed quantity of USP Quinapril Hydrochloride RS in Solvent to obtain a solution having a known concentration of about 1.08 mg per mL. Quantitatively dilute with Buffered solvent to obtain a solution having a known concentration of about 0.108 mg per mL.
Assay preparation— Transfer 10 Tablets to a 500-mL volumetric flask, add about 300 mL of Solvent, and sonicate until the Tablets have disintegrated. Shake by mechanical means for about 15 minutes, dilute with Solvent to volume, mix, and centrifuge. Dilute quantitatively, and stepwise if necessary, with Solvent to obtain a solution having a concentration of about 0.1 mg of quinapril per mL; and pass through a suitable filter, discarding the first portion of the filtrate.
Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 214-nm detector and a 6.0-mm × 4-cm column that contains 3-µm packing L10. The flow rate is about 1.2 mL per minute. Chromatograph the Standard preparation, and record the peak areas as directed for Procedure: the column efficiency is not less than 600 theoretical plates; the tailing factor is not more than 1.5; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure— Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the areas for the major peaks. Calculate the quantity, in mg, of quinapril (C25H30N2O5) in the portion of Tablets taken by the formula:
500CD(438.52/474.98)(rU / rS)
in which C is the concentration, in mg per mL, of USP Quinapril Hydrochloride RS in the Standard preparation; D is the dilution factor used to prepare the Assay preparation; 438.52 and 474.98 are the molecular weights of quinapril and quinapril hydrochloride, respectively; and rU and rS are the peak areas obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Sujatha Ramakrishna, Ph.D.
Senior Scientific Liaison
1-301-816-8349
(SM22010) Monographs - Small Molecules 2
Reference Standards RS Technical Services
1-301-816-8129
rstech@usp.org
711 Margareth R.C. Marques, Ph.D.
Senior Scientific Liaison
1-301-816-8106
(GCDF2010) General Chapters - Dosage Forms
USP35–NF30 Page 4500
Pharmacopeial Forum: Volume No. 34(5) Page 1182